Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Statistics

Total Valuation

AMLX has a market cap or net worth of $367.65 million. The enterprise value is $52.12 million.

Market Cap	367.65M
Enterprise Value	52.12M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

AMLX has 68.08 million shares outstanding. The number of shares has increased by 4.98% in one year.

Shares Outstanding	68.08M
Shares Change (YoY)	+4.98%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	10.11%
Owned by Institutions (%)	70.71%
Float	42.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.19
Forward PS	n/a
PB Ratio	1.37
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.66, with a Debt / Equity ratio of 0.01.

Current Ratio	4.66
Quick Ratio	4.48
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.22% and return on invested capital (ROIC) is -33.87%.

Return on Equity (ROE)	-51.22%
Return on Assets (ROA)	-28.28%
Return on Capital (ROIC)	-33.87%
Revenue Per Employee	$778,026
Profits Per Employee	-$431,951
Employee Count	384
Asset Turnover	0.76
Inventory Turnover	n/a

Taxes

In the past 12 months, AMLX has paid $3.51 million in taxes.

Income Tax	3.51M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.73% in the last 52 weeks. The beta is -0.55, so AMLX's price volatility has been lower than the market average.

Beta (5Y)	-0.55
52-Week Price Change	-65.73%
50-Day Moving Average	3.29
200-Day Moving Average	4.91
Relative Strength Index (RSI)	75.37
Average Volume (20 Days)	1,690,786

Short Selling Information

The latest short interest is 1.01 million, so 1.48% of the outstanding shares have been sold short.

Short Interest	1.01M
Short Previous Month	1.28M
Short % of Shares Out	1.48%
Short % of Float	2.41%
Short Ratio (days to cover)	0.76

Income Statement

In the last 12 months, AMLX had revenue of $298.76 million and -$165.87 million in losses. Loss per share was -$2.46.

Revenue	298.76M
Gross Profit	25.45M
Operating Income	-177.76M
Pretax Income	-162.36M
Net Income	-165.87M
EBITDA	-176.64M
EBIT	-177.76M
Loss Per Share	-$2.46

Balance Sheet

The company has $309.81 million in cash and $3.14 million in debt, giving a net cash position of $306.67 million or $4.50 per share.

Cash & Cash Equivalents	309.81M
Total Debt	3.14M
Net Cash	306.67M
Net Cash Per Share	$4.50
Equity (Book Value)	261.31M
Book Value Per Share	3.84
Working Capital	256.64M

Cash Flow

In the last 12 months, operating cash flow was -$58.69 million and capital expenditures -$869,000, giving a free cash flow of -$59.56 million.

Operating Cash Flow	-58.69M
Capital Expenditures	-869,000
Free Cash Flow	-59.56M
FCF Per Share	-$0.87

Margins

Gross margin is 8.52%, with operating and profit margins of -59.50% and -55.52%.

Gross Margin	8.52%
Operating Margin	-59.50%
Pretax Margin	-54.35%
Profit Margin	-55.52%
EBITDA Margin	-59.12%
EBIT Margin	-59.50%
FCF Margin	-19.93%

Dividends & Yields

AMLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.98%
Shareholder Yield	-4.98%
Earnings Yield	-46.23%
FCF Yield	-16.60%

Analyst Forecast

The average price target for AMLX is $5.20, which is -3.70% lower than the current price. The consensus rating is "Buy".

Price Target	$5.20
Price Target Difference	-3.70%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	-51.92%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AMLX has an Altman Z-Score of 5.32 and a Piotroski F-Score of 2.

Altman Z-Score	5.32
Piotroski F-Score	2